Radiation Risks From Diagnostic Procedures Examined

Share this article:
Radiation Risks From Diagnostic Procedures Examined
Radiation Risks From Diagnostic Procedures Examined

THURSDAY, Feb. 9 (HealthDay News) -- National strategies should be developed for the use of evidence-based criteria and improved oversight of equipment to minimize radiation exposure for patients undergoing diagnostic procedures, according to a study published online Feb. 3 in CA: A Cancer Journal for Clinicians.

Martha S. Linet, M.D., M.P.H., of the National Cancer Institute in Bethesda, Md., and associates reviewed epidemiologic data on cancer risks associated with diagnostic procedures. The authors reviewed the definitions of radiation doses, mechanisms of radiation carcinogenesis, epidemiologic studies of medical and other radiation sources and cancer risks, and diagnostic procedure dose trends. Cancer risks were described in experimental studies, and risks projected from current imaging procedures. They also proposed a framework of strategies to decrease radiation from diagnostic imaging.

To decrease the risk of future cancer from diagnostic procedures, the authors recommend the widespread use of evidence-based appropriateness criteria for decisions about imaging procedures; oversight of equipment to deliver the minimum radiation dose necessary to achieve clinical objectives; development of imaging procedure electronic lifetime records for patients; and a commitment by relevant medical and professional personnel to educate stakeholders in reducing radiation from diagnostic procedures.

"Professionals and professional organizations that play a key role in the appropriate utilization of medical imaging are the referring medical practitioners who are responsible for ensuring that a diagnostic procedure involving ionizing radiation is necessary for a patient's care and should be expected to do more good than harm (designated as justification)," the authors write.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Cancer 'vaccine' for advanced disease shows early progress

Cancer 'vaccine' for advanced disease shows early progress

Early progress has been made in developing a treatment that might one day help the immune system defend itself against cancer, but research is still in preliminary stages.

Clinician-patient relationship tied to health care outcomes

Clinician-patient relationship tied to health care outcomes

Meta-analysis of 13 randomized controlled trials shows small but significant effect from the patient-clinician relationship.

Patients see sharp increase in price of specialty drugs

Patients see sharp increase in price of specialty ...

Many Americans paying less for prescription drugs, but some are having to deal with sharp rises in cost of specialty meds.